IPHA — Innate Pharma SA

—
Nasdaq · Health Care · Biotechnology · CIK 1598599 · France
Last close
$1.33
Market Cap
$148.56M
52W High
$2.71
52W Low
$1.17
ADV30
20,927
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 34,726,000 6,461,000 75,234,000
Dec 2025 — — — — 62,719,000 28,092,000 84,423,000
Jun 2025 — — — — 92,937,000 53,704,000 87,793,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-455,164,000
Inventory
—
Receivables
$4,586,000
ST Investments
$4,435,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$9,005,000
EBITDA
$-53,309,000
Free Cash Flow
$-34,073,624
Enterprise Value
$163,650,384
Total Cash
$34,310,000
Total Debt
$22,573,000
Shares Out
111,700,347
Trailing EPS
$-0.64
Book Value
$-0.27
ROE
—
ROA
-38.8%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,787,000 -53,425,000 -49,177,000 62,719,000 84,423,000 -21,704,000 -32,559,000
Dec 2024 12,621,000 -51,576,000 -49,471,000 111,059,000 102,225,000 8,834,000 -6,896,000
Dec 2023 51,901,000 -12,669,000 -7,570,000 175,187,000 123,286,000 51,901,000 -52,755,000
Dec 2022 49,580,000 -16,425,000 -58,103,000 199,295,000 145,144,000 54,151,000 -19,155,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.59

Peers — same industry

TickerNameMarket CapLastDaily %
STRO SUTRO BIOPHARMA, INC. $148.08M $8.92 —
IVVD Invivyd, Inc. $151.09M $0.51 —
HUMA Humacyte, Inc. $139.18M $0.50 —
TARA Protara Therapeutics, Inc. $137.10M $2.32 —
IPHYF Innate Pharma SA $168.56M $1.51 —

News headlines (Yahoo Finance, 1h cache)

Innate Pharma stock tumbles after phase 1 trial data
2026-11-18 16:53 · Yahoo
Innate Pharma Presents Initial Phase 1 Clinical Data for IPH4502 at ENA 2026
2026-11-18 07:30 · Yahoo
Innate Pharma to Host In-Person and Virtual Event on IPH4502 on November 18, 2026
2026-11-11 06:00 · Yahoo
Innate Pharma Q3 Earnings Call Highlights
2026-11-05 14:14 · Yahoo
Innate Pharma Reports Third Quarter 2026 Business and Financial Update
2026-11-05 06:00 · Yahoo
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
2026-10-27 06:00 · Yahoo
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
2026-10-21 05:00 · Yahoo
Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update
2026-10-20 05:00 · Yahoo
Down 22% in 4 Weeks, Here's Why Innate Pharma (IPHA) Looks Ripe for a Turnaround
2026-10-08 12:35 · Yahoo
Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know
2026-09-23 16:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.